NCT03373695 is a NA clinical trial of Dissolve™ in Coronary In-stent Restenosis, sponsored by DK Medical Technology (Suzhou) Co., Ltd..

Who is sponsoring NCT03373695?

NCT03373695 is sponsored by DK Medical Technology (Suzhou) Co., Ltd..

What drugs are being tested in NCT03373695?

Interventions in NCT03373695: Dissolve™, SeQuent®Please.

What condition does NCT03373695 study?

NCT03373695 studies Coronary In-stent Restenosis.

Is NCT03373695 still recruiting?

NCT03373695 is currently completed. Last updated 20 February 2025.

Last reviewed 2025-02-20 · How we verify

NCT03373695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

Completed NA Last updated 20 February 2025

What this trial tests

NA trial testing Dissolve™ in Coronary In-stent Restenosis in 260 participants. Completed in 24 April 2024.

Timeline

22 February 2018

Primary endpoint
9 January 2020

24 April 2024

Quick facts

Lead sponsor	DK Medical Technology (Suzhou) Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	260
Start date	22 February 2018
Primary completion	9 January 2020
Estimated completion	24 April 2024
Sites	15 locations across China

Drugs / interventions tested

Dissolve™
SeQuent®Please

Conditions studied

Coronary In-stent Restenosis — all drugs for Coronary In-stent Restenosis →

Sponsor

DK Medical Technology (Suzhou) Co., Ltd.

Who can join

18 and older, any sex, with Coronary In-stent Restenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the efficacy and safety of treatment of coronary in-stent restenosis by Paclitaxel-eluting balloon catheter Dissolve™ versus SeQuent®Please, and the reference diameter of coronary artery stenosis is 2.5mm-4.0mm and the length ≤ 26mm.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis.
Liu S, Zhou Y, Shen Z, Chen H, et al · · 2023 · cited 11× · PMID 37045496 · DOI 10.1016/j.jcin.2022.12.018

Verify or expand the search:

Other DK Medical Technology (Suzhou) Co., Ltd. trials

Trials by the same sponsor.

NCT05608655 — DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis · NA · completed
NCT05250193 — DK Score Coronary Scoring Balloon: a RCT Trial to Evaluate Acute Lumen Gain (SCORE CHINA) · NA · completed
NCT04226599 — A Safety and Efficacy Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With DissolveAV · NA · completed
NCT03376646 — A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03373695 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DK Medical Technology (Suzhou) Co., Ltd.
Last refreshed: 20 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03373695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing